This protocol is judged by an institutional critique board, an independent group that critiques any medical trials involving individuals. If a analyze includes a Schedule I drug, after the board approves the protocol as ethical, the researchers need to make an application for an investigational new drug (IND) quantity through the FDA.If This is of